Author

Meng Yu

Karolinska University HospitalORCID 0000-0002-9798-6624Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Meng Yu1 paper · Army Medical University

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Ang Lin· 1 shared Anna Smed‐SörenseniD· 1 shared David M. MarkovitziD· 1 shared Ebba SohlbergiD· 1 shared Evelyn M. Covés-DatsoniD· 1 shared Faezzah BaharomiD· 1 shared Karin LoréiD· 1 shared Maureen Legendre· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Ang Lin

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A genetically engineered therapeutic lectin inhibits human influenza A virus infection and sustains robust virus-specific CD8 T cell expansion

Meng Yu, Ang Lin, Faezzah Baharom, Shuijie Li, Maureen Legendre, Evelyn M. Covés-Datson, Ebba Sohlberg, Susanne Schlisio, Karin Loré, David M. Markovitz, Anna Smed‐Sörensen

This study evaluates the antiviral and immunomodulatory effects of H84T BanLec on human immune cells and IAV-specific CD8 T cell responses.

PLoS Pathogens · May 7, 2025Peer-reviewedImmunology